Would a Two-Dose Rotavirus Vaccine Improve Health Outcomes While Reducing Costs in the Sultanate of Oman?

Value in Health                   
October–November 2017 Volume 20, Issue 9
http://www.valueinhealthjournal.com/current

ISPOR 20th Annual European Congress Research Abstracts
Break out Sessions
Would a Two-Dose Rotavirus Vaccine Improve Health Outcomes While Reducing Costs in the Sultanate of Oman?
X Li, Y Shehata, A Marijam, K Meszaros, S Noibi
Rotavirus is the most common cause of diarrhoea in young children. A recent study in Oman showed no significant disease reductions despite improved healthcare facilities and infection control measures. This study evaluated whether a paediatric vaccination programme with a two-dose Human Rotavirus Vaccine (HRV) would be cost-effective in Oman.